FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078045193> ?p ?o ?g. }

• W2078045193 endingPage "1663" @default.
• W2078045193 startingPage "1656" @default.
• W2078045193 abstract "One-hundred-two patients with malignant melanoma who had distant metastases surgically resected and were judged to be clinically free of disease (M. D. Anderson Stage IVA melanoma) were studied. The median survival for all the patients from time of diagnosis of stage IVA disease was 18 months. The site of the resected metastases did not appear to influence survival, being approximately the same for the brain (15 months), lung (16 months), intraabdominal (18 months), and skin and/or lymph nodes (23 months). The site of the resected metastases also did not influence the median disease-free interval. Patients who had metastases resected from several organs at the same time had a median survival of 15 months, which was similar to that of patients with one resected site. Patients who were rendered Stage IVA on several occasions by surgical excisions had a median survival of 36 months. Thirty-five patients received surgery only and 67 patients received adjuvant chemotherapy, immunotherapy, or combined chemoimmunotherapy after surgery. For the group treated with surgery only, the median disease-free interval and survival from diagnosis of stage IVA disease were 6 months and 16 months, respectively, and for the adjuvant group 6 months and 21 months, respectively. Specifically, by the type of adjuvant therapy, the median disease-free interval and survival from stage IVA for 23 patients receiving Corynebacterium parvum were 6.9 and 19 months; for 39 patients receiving BCG, eight months and 26 months; for 24 patients receiving BCG + DTIC, eight and 17.4 months; and for all 51 DTIC treated patients 6.3 and 17.8 months, respectively. Patients receiving BCG had a median survival superior to the surgery only group (P = 0.02). An increase in survival was seen predominantly in patients who achieved IVA status more than once and received BCG. Patients with recurrent soft-tissue metastases appeared to benefit most from BCG in prolonging the disease-free interval. Only 1/10 treated by surgery alone had a disease-free interval longer than 1 year, compared with 9/16 who received BCG (P = 0.01). Stage IVA melanoma appears to be distinctly different in prognosis from Stage IVB melanoma and should be classified separately. Patients with recurrent soft-tissue disease may benefit significantly from treatment with BCG." @default.
• W2078045193 created "2016-06-24" @default.
• W2078045193 creator A5001610159 @default.
• W2078045193 creator A5012479785 @default.
• W2078045193 creator A5017764456 @default.
• W2078045193 creator A5038302480 @default.
• W2078045193 creator A5038348446 @default.
• W2078045193 creator A5043892380 @default.
• W2078045193 creator A5046099119 @default.
• W2078045193 creator A5048531550 @default.
• W2078045193 creator A5055030811 @default.
• W2078045193 creator A5059946830 @default.
• W2078045193 creator A5064210978 @default.
• W2078045193 creator A5078169692 @default.
• W2078045193 creator A5082916862 @default.
• W2078045193 creator A5090554156 @default.
• W2078045193 date "1982-10-15" @default.
• W2078045193 modified "2023-09-23" @default.
• W2078045193 title "The natural history of resectable metastatic melanoma (Stage IVA Melanoma)" @default.
• W2078045193 cites W1973064794 @default.
• W2078045193 cites W1981998179 @default.
• W2078045193 cites W1984511566 @default.
• W2078045193 cites W2004900202 @default.
• W2078045193 cites W2007941217 @default.
• W2078045193 cites W2036609907 @default.
• W2078045193 cites W2048500337 @default.
• W2078045193 cites W2051935989 @default.
• W2078045193 cites W2057577614 @default.
• W2078045193 cites W2058067215 @default.
• W2078045193 cites W2069390263 @default.
• W2078045193 cites W2094911762 @default.
• W2078045193 cites W2318955384 @default.
• W2078045193 cites W2323277523 @default.
• W2078045193 cites W2338415229 @default.
• W2078045193 cites W2409912500 @default.
• W2078045193 doi "https://doi.org/10.1002/1097-0142(19821015)50:8<1656::aid-cncr2820500833>3.0.co;2-l" @default.
• W2078045193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7116298" @default.
• W2078045193 hasPublicationYear "1982" @default.
• W2078045193 type Work @default.
• W2078045193 sameAs 2078045193 @default.
• W2078045193 citedByCount "113" @default.
• W2078045193 countsByYear W20780451932012 @default.
• W2078045193 countsByYear W20780451932016 @default.
• W2078045193 countsByYear W20780451932017 @default.
• W2078045193 countsByYear W20780451932018 @default.
• W2078045193 countsByYear W20780451932019 @default.
• W2078045193 countsByYear W20780451932020 @default.
• W2078045193 countsByYear W20780451932021 @default.
• W2078045193 countsByYear W20780451932023 @default.
• W2078045193 crossrefType "journal-article" @default.
• W2078045193 hasAuthorship W2078045193A5001610159 @default.
• W2078045193 hasAuthorship W2078045193A5012479785 @default.
• W2078045193 hasAuthorship W2078045193A5017764456 @default.
• W2078045193 hasAuthorship W2078045193A5038302480 @default.
• W2078045193 hasAuthorship W2078045193A5038348446 @default.
• W2078045193 hasAuthorship W2078045193A5043892380 @default.
• W2078045193 hasAuthorship W2078045193A5046099119 @default.
• W2078045193 hasAuthorship W2078045193A5048531550 @default.
• W2078045193 hasAuthorship W2078045193A5055030811 @default.
• W2078045193 hasAuthorship W2078045193A5059946830 @default.
• W2078045193 hasAuthorship W2078045193A5064210978 @default.
• W2078045193 hasAuthorship W2078045193A5078169692 @default.
• W2078045193 hasAuthorship W2078045193A5082916862 @default.
• W2078045193 hasAuthorship W2078045193A5090554156 @default.
• W2078045193 hasConcept C141071460 @default.
• W2078045193 hasConcept C146357865 @default.
• W2078045193 hasConcept C151730666 @default.
• W2078045193 hasConcept C2776283816 @default.
• W2078045193 hasConcept C2776694085 @default.
• W2078045193 hasConcept C2776755627 @default.
• W2078045193 hasConcept C2777658100 @default.
• W2078045193 hasConcept C2777982462 @default.
• W2078045193 hasConcept C2780790343 @default.
• W2078045193 hasConcept C2780964509 @default.
• W2078045193 hasConcept C502942594 @default.
• W2078045193 hasConcept C71924100 @default.
• W2078045193 hasConcept C86803240 @default.
• W2078045193 hasConceptScore W2078045193C141071460 @default.
• W2078045193 hasConceptScore W2078045193C146357865 @default.
• W2078045193 hasConceptScore W2078045193C151730666 @default.
• W2078045193 hasConceptScore W2078045193C2776283816 @default.
• W2078045193 hasConceptScore W2078045193C2776694085 @default.
• W2078045193 hasConceptScore W2078045193C2776755627 @default.
• W2078045193 hasConceptScore W2078045193C2777658100 @default.
• W2078045193 hasConceptScore W2078045193C2777982462 @default.
• W2078045193 hasConceptScore W2078045193C2780790343 @default.
• W2078045193 hasConceptScore W2078045193C2780964509 @default.
• W2078045193 hasConceptScore W2078045193C502942594 @default.
• W2078045193 hasConceptScore W2078045193C71924100 @default.
• W2078045193 hasConceptScore W2078045193C86803240 @default.
• W2078045193 hasIssue "8" @default.
• W2078045193 hasLocation W20780451931 @default.
• W2078045193 hasLocation W20780451932 @default.
• W2078045193 hasOpenAccess W2078045193 @default.
• W2078045193 hasPrimaryLocation W20780451931 @default.
• W2078045193 hasRelatedWork W1587130977 @default.
• W2078045193 hasRelatedWork W1972417888 @default.
• W2078045193 hasRelatedWork W1992414795 @default.

• next